[Cardiac stimulation and heart insufficiency]

C Alonso1

  • 1Service de cardiologie, hôpital Pontchaillou, rue Henri-le-Guillou, 35033 Rennes, France. christine.alonso@wanadoo.fr

Annales De Cardiologie Et D'Angeiologie
|January 31, 2003
PubMed

Insights

Biventricular pacing effectively treats dilated cardiomyopathy and heart failure by restoring normal heart rhythm. This cardiac resynchronization therapy improves patient outcomes and quality of life.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Context:

  • Dilated cardiomyopathy often involves conduction disorders, impairing heart function.
  • Conventional pacing has limitations in addressing complex cardiac activation issues.

Purpose:

  • To evaluate biventricular pacing for restoring normal cardiac activation in dilated cardiomyopathy.
  • To assess the efficacy of biventricular pacing in improving heart failure symptoms and function.

Summary:

  • Biventricular pacing aims to correct intraventricular asynchrony by simultaneously pacing both ventricles.
  • Studies show acute hemodynamic improvements and chronic benefits in exercise tolerance and quality of life.
  • Development of specialized tools has made left ventricular pacing safe and feasible.

Impact:

  • Biventricular pacing is a viable treatment for drug-refractory heart failure with systolic dysfunction and conduction disorders.
  • This therapy offers significant improvements for patients with dilated cardiomyopathy.
  • Advancements in pacing technology enhance treatment safety and effectiveness.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...